Antimicrobial Resistance Practice Questions

Q: All are true about ESBL except -

Resistant to carbapenems. ***Resistant to carbapenems*** - **ESBL (Extended-Spectrum Beta-Lactamase)**-producing bacteria are typically **susceptible to carbapenems**. Carbapenems are a primary treatment option for serious ESBL infections. - Resistance to carbapenems suggests the presence of other resistance mechanisms, such as **carbapenemases**, not ESBLs. *Classification is based on 3rd generation cephalosporin sensitivity* - ESBLs are specifically defined by their ability to hydrolyze and confer resistance to **extended-spectrum cephalosporins** (e.g., ceftriaxone, ceftazidime) and aztreonam. - This characteristic resistance to third-generation cephalosporins is key to their definition and clinical identification. *Cephalosporin sensitivity testing is required to confirm ESBL* - **Phenotypic confirmatory tests** for ESBLs involve demonstrating increased resistance to an extended-spectrum cephalosporin alone compared to the same cephalosporin combined with a **beta-lactamase inhibitor** like clavulanic acid. - This testing is crucial for accurate detection and guiding appropriate antibiotic therapy. *Ambler classification is based on molecular structure* - The **Ambler classification system** categorizes beta-lactamases into classes A, B, C, and D based on their **amino acid sequence homology** and their active site mechanisms. - This classification helps in understanding the biochemical properties and substrate profiles of different beta-lactamases, including ESBLs.

Q: Transfer of drug resistance in *Staphylococcus* is by:

Transduction. ***Transduction*** - **Transduction** is a common mechanism for the transfer of antibiotic resistance genes in *Staphylococcus aureus*, particularly for methicillin resistance (*mecA* gene). - This process involves **bacteriophages (viruses)** infecting bacterial cells and transferring genetic material, including resistance genes, from one bacterium to another. *Conjugation* - **Conjugation** involves direct cell-to-cell contact between bacteria, typically through a **pilus**, to transfer plasmids containing resistance genes. - While conjugation can occur in staphylococci, it is less common for widespread drug resistance dissemination than transduction, especially for *mecA*. *Transfection* - **Transfection** is the process of introducing **foreign nucleic acids (DNA or RNA)** into eukaryotic cells, often used in molecular biology research. - This term is not typically used to describe natural gene transfer mechanisms between bacteria. *Transformation* - **Transformation** involves the uptake of **naked DNA** from the environment by a bacterial cell. - While *Staphylococcus aureus* can undergo transformation, it is generally less efficient and frequent than transduction for the acquisition of significant resistance traits, especially in clinical settings.

Q: Multi drug resistant tuberculosis is defined as resistance to?

INH and Rifampicin. ***INH and Rifampicin*** - **Multidrug-resistant tuberculosis (MDR-TB)** is specifically defined by resistance to at least **isoniazid (INH)** and **rifampicin** [1], which are the two most potent first-line anti-TB drugs. - This dual resistance makes treatment significantly more challenging and prolonged compared to drug-susceptible TB. *Rifampicin and Pyrazinamide* - While resistance to these drugs is serious, it does not specifically define MDR-TB unless resistance to **isoniazid** is also present. - **Pyrazinamide** is another first-line drug, but its resistance pattern alone with rifampicin does not meet the MDR-TB criteria. *Resistance to all first-line drugs* - Resistance to all four first-line drugs (isoniazid, rifampicin, pyrazinamide, and ethambutol) [1] is classified as **Extensively Drug-Resistant TB (XDR-TB)**, a more severe form of resistance than MDR-TB. - MDR-TB specifically refers to resistance to **INH and rifampicin**, not necessarily all first-line drugs. *INH and Pyrazinamide* - While resistance to both **isoniazid** and **pyrazinamide** is a concern, it does not meet the definition of MDR-TB. - The definition requires resistance to **rifampicin** in addition to isoniazid.

Q: The following phenomenon is responsible for antibiotic resistance in bacteria due to slime production -

Biofilm formation. ***Biofilm formation*** - **Slime production** by bacteria is a key component of **biofilm formation**, creating a protective matrix around bacterial colonies. - This **biofilm acts as a physical barrier**, reducing the penetration of antibiotics and host immune cells, thereby contributing significantly to **antibiotic resistance**. *Mutation evolving a target by pass mechanism* - This refers to a genetic change where bacteria develop a **new metabolic pathway** or enzyme to bypass the inhibited target of an antibiotic. - While it causes antibiotic resistance, it is a **genetic alteration** and not directly linked to **slime production** or the physical protection offered by a biofilm. *Co-aggregation* - **Co-aggregation** describes the specific interaction and adherence between different species of bacteria. - While important for the **development of complex microbial communities**, it is a phenomenon of bacterial interaction, not the primary mechanism by which **slime production** leads to antibiotic resistance. *Mutation evolving in altered target site for antibiotics* - This describes a genetic mutation that modifies the specific **molecular target** (e.g., ribosome, cell wall enzyme) that an antibiotic usually binds to. - This alteration reduces the antibiotic's binding affinity and effectiveness, but it is a **molecular mechanism of resistance** distinct from the physical barrier provided by **slime production** in biofilms.

Q: Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :

Carbapenems. ***Carbapenems*** - **Extended-spectrum beta-lactamases (ESBLs)** typically do not hydrolyze **carbapenems**, making these antibiotics generally effective against most ESBL-producing bacteria. - The retention of activity against carbapenems is a key distinction between ESBLs and other beta-lactamases like **carbapenemases**. *Oxyimino-cephalosporins* - ESBLs are specifically named for their ability to hydrolyze and inactivate **oxyimino-cephalosporins**, such as **cefotaxime**, **ceftriaxone**, and **ceftazidime**. - This hydrolysis makes these vital third-generation cephalosporins ineffective for treating infections caused by ESBL-producing organisms. *Penicillins* - ESBLs can effectively hydrolyze and render many **penicillins** inactive, especially those lacking beta-lactamase inhibitors. - This broadens the resistance spectrum beyond just cephalosporins to include common penicillins. *Cephalosporins* - ESBLs primarily confer resistance to a wide range of **cephalosporins**, particularly the **first-, second-, and third-generation agents**. - This resistance is a major clinical challenge, necessitating the use of alternative antibiotic classes.

Q: The molecular basis of penicillin resistance in *S. pneumoniae* is:

Alteration of penicillin-binding protein. ***Alteration of penicillin-binding protein*** - The primary mechanism of **penicillin resistance in *Streptococcus pneumoniae*** involves modifications to its **penicillin-binding proteins (PBPs)**, which are the targets of penicillin. - These alterations reduce the affinity of PBPs for penicillin, allowing cell wall synthesis to continue even in the presence of the antibiotic. *Alteration in cell membranes* - Changes in cell membranes are not the primary mechanism of **penicillin resistance** in bacteria. - **Penicillins** primarily target the **bacterial cell wall**, not the cell membrane. *Alteration in the cell wall* - While penicillin resistance *involves* the cell wall, the direct "alteration in the cell wall" itself is not the molecular basis. - The key is the change in the **PBPs** located within or associated with the cell wall, not a general change in the cell wall structure. *Production of beta-lactamase enzyme* - **Beta-lactamase production** is a common mechanism of penicillin resistance in many bacteria (e.g., *Staphylococcus aureus*, *Haemophilus influenzae*), but it is **not the primary mechanism for penicillin resistance in *Streptococcus pneumoniae***. - *S. pneumoniae* primarily relies on **altered PBPs** to evade penicillin, rather than enzymatic degradation of the antibiotic.

Q: Drug resistance is not transmitted by-

Ribosomes. ***Ribosomes*** - Ribosomes are responsible for **protein synthesis** and do not carry or transmit genetic information for **drug resistance**. - While ribosomal mutations can sometimes lead to drug resistance, the ribosome itself is not a vehicle for its transmission between bacteria. *Plasmids* - **Plasmids** are small, extrachromosomal DNA molecules that can replicate independently and are a primary means of **horizontal gene transfer** for drug resistance genes. - They can be easily transferred between bacteria through **conjugation**, rapidly spreading resistance. *Chromosomes* - **Drug resistance genes** can be located on the bacterial chromosome and are passed down to daughter cells during **vertical gene transfer** (cell division). - While less frequent for initial acquisition compared to plasmids, chromosomal mutations and integrated resistance genes are significant causes of **antibiotic resistance**. *Transposons* - **Transposons**, or jumping genes, are DNA sequences that can move from one location in the genome to another, including between **plasmids and chromosomes**. - They often carry **antibiotic resistance genes** and facilitate their spread within a bacterial genome or between different genetic elements.

Q: All of the following are true about methicillin resistance in MRSA, except:

Resistance is primarily mediated/transmitted by plasmids. ***Resistance is primarily mediated/transmitted by plasmids*** - Methicillin resistance in MRSA is primarily mediated by the acquisition of the **mecA gene**, which encodes for an altered **penicillin-binding protein (PBP2a)**. - The mecA gene is located on a **staphylococcal chromosomal cassette mec (SCCmec)**, a mobile genetic element integrated into the bacterial chromosome, and **not transmitted via plasmids**. - This is the **false statement** and hence the correct answer to this "except" question. *Resistance is produced as a result of altered PBPs* - This statement is **true** as MRSA acquires the **mecA gene**, which encodes for an altered penicillin-binding protein, **PBP2a**. - **PBP2a** has a low affinity for beta-lactam antibiotics, allowing the bacterium to synthesize its cell wall even in the presence of these drugs. *Resistance may be missed at incubation temperature of 37°C during susceptibility testing* - This statement is **true**; **MRSA expression** can be heterogeneous and temperature-dependent. - Optimal detection of methicillin resistance often requires incubation at **lower temperatures (e.g., 30-35°C)** and/or the addition of salt (2-4% NaCl), as 37°C can sometimes mask the heterogeneous expression of resistance. *Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics* - This statement is **true**; the presence of **PBP2a** results in reduced binding of beta-lactam antibiotics to their target. - This leads to **increased MICs** for methicillin and other beta-lactam antibiotics, defining the resistance phenotype.

Q: Which of the following is true about Extended spectrum beta-lactamases?

Plasmid mediated. ***Plasmid mediated*** - **Extended-spectrum beta-lactamases (ESBLs)** are primarily encoded on **plasmids**, which allows for easy horizontal transfer of resistance genes between bacteria. - This **plasmid-mediated dissemination** is a major reason for the rapid spread of ESBL resistance among various bacterial species. *Only seen in gram positive bacteria* - ESBLs are predominantly found in **Gram-negative bacteria**, particularly members of the **Enterobacteriaceae family** like *E. coli* and *Klebsiella pneumoniae*. - While some beta-lactamases exist in Gram-positive bacteria, ESBLs specifically refer to those with an extended spectrum of activity against modern beta-lactams in Gram-negative organisms. *Only seen in gram negative bacteria* - While **ESBLs are predominantly found in Gram-negative bacteria**, the phrasing "only seen in gram negative bacteria" is too restrictive because there have been rare reports of ESBL genes detected in some Gram-positive strains, though this is not their primary epidemiology. - The main concern with ESBLs lies in their prevalence and impact on Gram-negative infections. *Associated only in community acquired disease* - ESBLs are associated with both **hospital-acquired (nosocomial)** and **community-acquired infections**. - The prevalence of community-acquired ESBL infections has been increasing, posing a significant public health challenge.

Question 1

All are true about ESBL except -

Accepted Answer

Resistant to carbapenems

Answer

Classification is based on 3rd generation cephalosporin sensitivity

Answer

Cephalosporin sensitivity testing is required to confirm ESBL

Answer

Ambler classification is based on molecular structure

Question 2

Transfer of drug resistance in *Staphylococcus* is by:

Accepted Answer

Transduction

Answer

Conjugation

Answer

Transfection

Answer

Transformation

Question 3

Multi drug resistant tuberculosis is defined as resistance to?

Accepted Answer

INH and Rifampicin

Answer

Rifampicin and Pyrazinamide

Answer

Resistance to all first line drugs

Answer

INH and Pyrazinamide

Question 4

XDR means extensive drug resistance to

Accepted Answer

Fluoroquinolone + at least one Group A drug (bedaquiline/linezolid)

Answer

Minimum of 1 injectable drug

Answer

H+R

Answer

1 Fluoroquinolone

Question 5

The following phenomenon is responsible for antibiotic resistance in bacteria due to slime production -

Accepted Answer

Biofilm formation

Answer

Mutation evolving a target by pass mechanism

Answer

Co-aggregation

Answer

Mutation evolving in altered target site for antibiotics

Question 6

Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :

Accepted Answer

Carbapenems

Answer

Oxyimino-cephalosporins

Answer

Penicillins

Answer

Cephalosporins

Question 7

The molecular basis of penicillin resistance in *S. pneumoniae* is:

Accepted Answer

Alteration of penicillin-binding protein

Answer

Alteration in cell membranes

Answer

Alteration in the cell wall

Answer

Production of beta-lactamase enzyme

Question 8

Drug resistance is not transmitted by-

Accepted Answer

Ribosomes

Answer

Plasmids

Answer

Chromosomes

Answer

Transposons

Question 9

All of the following are true about methicillin resistance in MRSA, except:

Accepted Answer

Resistance is primarily mediated/transmitted by plasmids

Answer

Resistance is produced as a result of altered PBPs

Answer

Resistance may be missed at incubation temperature of 37°C during susceptibility testing

Answer

Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics

Question 10

Which of the following is true about Extended spectrum beta-lactamases?

Accepted Answer

Plasmid mediated

Answer

Only seen in gram positive bacteria

Answer

Only seen in gram negative bacteria

Answer

Associated only in community acquired disease

Antimicrobial Resistance — MCQs

Antimicrobial Resistance — MCQs

On this page

Practice by Chapter

Want unlimited practice?